Criteria | At home % | In care % | OR (95% CI) | Severity rating | |
Unadjusted | Adjusted* | ||||
Long-acting benzodiazepines | 6.36 | 11.13 | 1.85 (1.68 to 2.04) | 1.62 (1.45 to 1.81)‡ | High |
Nitrofurantoin | 2.46 | 5.84 | 2.46 (2.15 to 2.81) | 1.52 (1.30 to 1.76)‡ | High |
Fluoxetine | 2.10 | 4.83 | 2.37 (2.05 to 2.74) | 2.25 (1.91 to 2.65)‡ | High |
Muscle relaxants | 1.69 | 3.84 | 2.32 (1.97 to 2.73) | 1.42 (1.19 to 1.70)‡ | High |
Dipyridamole | 1.47 | 3.75 | 2.61 (2.21 to 3.08) | 1.74 (1.45 to 2.09)‡ | Low |
Amitriptyline | 7.76 | 5.99 | 0.76 (0.67 to 0.86) | 0.59 (0.51 to 0.67)§ | High |
NSAIDs | 3.92 | 1.56 | 0.39 (0.31 to 0.49) | 0.42 (0.33 to 0.54)§ | High |
Gastrointestinal antispasmodic | 1.06 | 0.92 | 0.87 (0.63 to 1.18) | 0.70 (0.51 to 0.98)§ | High |
Doxasozin | 5.66 | 2.15 | 0.37 (0.30 to 0.49) | 0.29 (0.24 to 0.36)§ | Low |
Cimetidine | 0.84 | 0.48 | 0.57 (0.37 to 0.88) | 0.48 (0.31 to 0.75)§ | Low |
Ferrous sulphate† >325 mg/d | 6.61 | 13.93 | 1.32 (1.02 to 1.70) | 0.76 (0.58 to 1.01) | Low |
Anticholinergics/antihistamines | 3.34 | 4.7 | 1.42 (1.23 to 1.64) | 1.05 (0.90 to 1.23) | High |
Digoxin† >125 mg/day | 1.60 | 2.65 | 1.05 (0.62 to 1.77) | 0.74 (0.43 to 1.29) | Low |
Amiodarone | 0.68 | 0.88 | 1.29 (0.93 to 1.79) | 0.76 (0.54 to 1.08) | High |
↵* Age, sex and polypharmacy were adjusted for in all analyses.
↵† Results extrapolated from patients registered with diabetes.
↵‡ Significantly higher PIM in ‘in care’ patients.
↵§ Significantly higher PIM in ‘at home’ patients.
NSAID, nonsteroidal anti-inflammatory drug; PIM, potentially inappropriate medicine.